Article citationsMore>>

Brose, M.S., Worden, F.P., Newboid, K.L., Guo, M. and Hurria, A. (2017) Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SLECT Trial. Journal of Clinical Oncology, 35, 2692-2699.
https://doi.org/10.1200/JCO.2016.71.6472

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top